TROW PRICE T ROWE GROUP INC
Investment Advice · Nasdaq · SEC CIK 1113169 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.9%
TTM net income YoY5.1%
TTM EPS YoY7.7%
Revenue 3-yr CAGR6.7%
Net income 3-yr CAGR10.6%
Margins
Gross margin—
Operating margin32.0%
Net margin28.4%
FCF margin20.7%
EBITDA margin—
Returns
ROE19.7%
ROA14.2%
ROIC (approx.)25.4%
Asset turnover0.50x
Leverage & solvency
Liabilities / assets21.9%
Debt / equity0.00x
Current ratio—
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.85x
Accruals ratio2.1%
Payout ratio52.2%
Capex / revenue3.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $7.31B | $7.09B | $6.46B | $6.49B | $7.67B |
| Operating income | $2.19B | $2.33B | $1.99B | $2.37B | $3.71B |
| Pretax income | $2.88B | $2.82B | $2.49B | $1.95B | $3.99B |
| Income tax | $667.20M | $683.80M | $654.60M | $498.60M | $896.10M |
| Net income | $2.09B | $2.10B | $1.79B | $1.56B | $3.08B |
| EPS (basic) | 9.26 | 9.18 | 7.78 | 6.73 | 13.25 |
| EPS (diluted) | 9.24 | 9.15 | 7.76 | 6.70 | 13.12 |
| Dividends declared per share | 5.08 | 4.96 | 4.88 | 4.80 | 4.32 |
| Weighted avg. shares (diluted) | 220.30M | 223.30M | 224.80M | 227.10M | 228.80M |
| Balance sheet | |||||
| Cash & equivalents | $3.38B | $2.71B | $2.14B | $1.87B | $1.62B |
| PP&E, net | $845.30M | $977.00M | $806.60M | $755.70M | $736.20M |
| Goodwill | $2.64B | $2.64B | $2.64B | $2.64B | $2.69B |
| Intangibles | $274.20M | $368.10M | $507.30M | $629.80M | $913.40M |
| Total assets | $14.34B | $13.47B | $12.28B | $11.64B | $12.51B |
| Total liabilities | $2.29B | $2.02B | $1.99B | $1.96B | $2.26B |
| Shareholders' equity | $10.86B | $10.35B | $9.51B | $8.84B | $9.02B |
| Shares outstanding | 218.56M | 222.97M | — | — | — |
| Cash flow statement | |||||
| Operating cash flow | $1.75B | $1.69B | $1.22B | $2.36B | $3.45B |
| Capital expenditure | $274.20M | $423.40M | $307.90M | $237.60M | $239.10M |
| Free cash flow | $1.48B | $1.26B | $911.20M | $2.12B | $3.21B |
| Investing cash flow | $230.30M | -$177.50M | $128.20M | -$41.50M | -$1.10B |
| Financing cash flow | -$1.28B | -$936.60M | -$1.08B | -$2.08B | -$2.99B |
| Stock-based compensation | $216.90M | $247.30M | $265.60M | $285.40M | $274.60M |
| Dividends paid | $1.14B | $1.14B | $1.12B | $1.11B | $1.70B |
| Share buybacks | $620.90M | $337.20M | $254.40M | $849.80M | $1.14B |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.